Thomas Havenith
Impact in
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Pneumonia and Respiratory Infections 2
- Co-authors
- Chris J.G. Bakker (1 shared paper)Clemens Bos (1 shared paper)J. Frank W. Nijsen (1 shared paper)Jan‐Henry Seppenwoolde (1 shared paper)Alfred D. van het Schip (1 shared paper)Rob E. Aarnoutse (2 shared papers)K. Hoogtanders (2 shared papers)Luuk B. Hilbrands (2 shared papers)
- Journals
- Radiology (1 paper)Transplant International (1 paper)Therapeutic Drug Monitoring (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- NetherlandsCzechiaCuracao
In The Last Decade
Thomas Havenith
11 papers receiving 133 citations
Peers
Comparison fields: 5 of 55
- Transplantation 21
- Hepatology 29
- Molecular Medicine 15
- Applied Microbiology and Biotechnology 4
- Radiology, Nuclear Medicine and Imaging 45
Countries citing papers authored by Thomas Havenith
This map shows the geographic impact of Thomas Havenith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Havenith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Havenith more than expected).
Fields of papers citing papers by Thomas Havenith
This network shows the impact of papers produced by Thomas Havenith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Havenith. The network helps show where Thomas Havenith may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Havenith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 57 | |
| 2 | 2015 | 25 | |
| 3 | 2014 | 20 | |
| 4 | 2019 | 9 | |
| 5 | 2014 | 6 | |
| 6 | 2017 | 6 | |
| 7 | [A patient with a life-threatening disulfiram-ethanol reaction]. | 2013 | 3 |
| 8 | 2017 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2018 | 2 | |
| 11 | 2020 | 1 |
About Thomas Havenith
Thomas Havenith is a scholar working on Pharmacology, Epidemiology, Pediatrics, Perinatology and Child Health, Infectious Diseases and Molecular Medicine, having authored 11 papers that have together received 134 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Pneumonia and Respiratory Infections (2 papers), HIV/AIDS drug development and treatment (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Transplantation (21 citations), Hepatology (29 citations), Molecular Medicine (15 citations), Applied Microbiology and Biotechnology (4 citations) and Radiology, Nuclear Medicine and Imaging (45 citations). Thomas Havenith has collaborated with scholars based in Netherlands, Czechia and Curacao. Frequent co-authors include Chris J.G. Bakker, Clemens Bos, J. Frank W. Nijsen, Jan‐Henry Seppenwoolde, Alfred D. van het Schip, Rob E. Aarnoutse, K. Hoogtanders, Luuk B. Hilbrands, A. Rogier T. Donders and Cathrien A. Bruggeman. Their work appears in journals such as Radiology, Transplant International, Therapeutic Drug Monitoring, Cancer Chemotherapy and Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.